Aging GSD-1a patients exhibit marked variability in the progression of the severity of symptoms and complications, including the link between the onset of HCA and HCC and the metabolic control of the disease, the presence of systemic indices of inflammation, and the renal pathogenesis and its correlation with the metabolic imbalance. This evidence concerns the gene G6PC1 and hepatocellular carcinoma.